Cytospire Therapeutics
cytospire.comLocations
London, UK
industry
Biotechnology
Size
11 - 50 employees
Stage
Seed
founded in
2023
Cytospire Therapeutics is a London-based biotechnology company specializing in the development of next-generation cancer immunotherapies. The company officially emerged from stealth in early 2024 and is led by CEO Natalie Mount, who previously headed Takeda-acquired startups Adaptate Biotherapeutics and GammaDelta Therapeutics.
Something looks off?Open jobs at Cytospire Therapeutics
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.